(Press-News.org) In 2 large studies, the association between aspirin use and risk of colorectal cancer was affected by mutation of the gene BRAF, with regular aspirin use associated with a lower risk of BRAF-wild-type colorectal cancer but not with risk of BRAF-mutated cancer, findings that suggest that BRAF-mutant colon tumor cells may be less sensitive to the effect of aspirin, according to a study in the June 26 issue of JAMA.
Colorectal cancer is a leading cause of cancer-related death worldwide. Randomized controlled trials have demonstrated that aspirin use reduces the risk of colorectal cancer, according to background information in the article. Experimental evidence has suggested that BRAF-mutant colonic cells might be less sensitive to the antitumor effects of aspirin than BRAF-wild-type (the typical form of a gene as it occurs in nature) neoplastic cells.
Reiko Nishihara, Ph.D., of the Dana-Farber Cancer Institute, Boston, and colleagues examined the association of aspirin use with the risk of colorectal cancer according to BRAF mutation status. The researchers collected biennial questionnaire data on aspirin use and followed up participants in the Nurses' Health Study (from 1980) and the Health Professionals Follow-up Study (from 1986) until July 2006 for cancer incidence and until January 2012 for cancer mortality.
Among 127,865 individuals, 1,226 incident rectal and colon cancers were identified with available molecular data. The researchers found that regular aspirin use was associated with a significantly lower risk (27 percent) of BRAF-wild-type cancer. Regular aspirin use was not associated with a lower risk of BRAF-mutated cancer. "The association of aspirin use with colorectal cancer risk differed significantly according to BRAF mutation status."
The authors also observed a lower risk of BRAF-wild-type cancer with increasing aspirin tablets per week; however, there was not a significant trend in risk reduction for BRAF-mutated cancer. "The association of aspirin tablets per week with cancer risk differed significantly by BRAF mutation status. Compared with individuals who reported no aspirin use, a significantly lower risk of BRAF-wild-type cancer was observed among individuals who used 6 to 14 tablets of aspirin per week and among those who used more than 14 tablets of aspirin per week."
In addition, longer duration of aspirin use was associated with significant risk reduction for BRAF-wild-type cancer, whereas duration of aspirin use was not significantly associated with BRAF-mutated cancer risk.
"There was no statistically significant interaction between post-diagnosis aspirin use and BRAF mutation status in colorectal cancer-specific or overall survival analysis. This suggests that the potential protective effect of aspirin may differ by BRAF status in the early phase of tumor evolution before clinical detection but not during later phases of tumor progression," the authors write.
"The identification of specific cancer-subtypes that are prevented by aspirin is important for several reasons. First, it enhances our understanding of the molecular pathogenesis of colorectal neoplasia and the mechanisms through which aspirin may exert its antineoplastic effects. Second, development of clinical, genetic, or molecular predictors of specific subtypes of colorectal cancer might lead to the development of more tailored screening or chemo-preventive strategies. Nevertheless, given the modest absolute risk difference, further investigations are necessary to evaluate clinical implications of our findings. Lastly, our data provide additional support for a causal association between aspirin use and risk reduction for a specific subtype of colorectal cancers. Accumulating evidence supports preventive effect of aspirin against colorectal cancer."
(JAMA. 2013;309(24):2563-2571; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Differential Effects of Aspirin Before and After Diagnosis of Colorectal Cancer
In an accompanying editorial, Boris Pasche, M.D., Ph.D., of the University of Alabama at Birmingham, (and JAMA contributing editor), comments on the findings of this study.
"Nishihara el al derived their report from the Nurses' Health Study and the Health Professionals Follow-up Study, which include a large number of female and male health professionals. This population is predominantly white: 98 percent of the participants in the Nurses' Health Study and 95 percent of participants in the Health Professionals Follow-up Study are of a non-Hispanic white ethnic background. However, black individuals have the highest incidence of colorectal cancer in the United States and represent the ethnic group for whom colorectal cancer prevention may have the greatest benefit. Therefore, it will be important to determine whether the findings reported by Nishihara et al are confirmed in black individuals."
"In summary, these results identify biomarkers of response to aspirin administered either preventively or therapeutically and are likely to help tailor the use of aspirin in the prevention and treatment of colorectal cancer."
(JAMA. 2013;309(24):2598-2599; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: Please see the article for additional information, including financial disclosures, funding and support, etc.
###
Gene mutation may have effect on benefit of aspirin use for colorectal cancer
2013-06-26
ELSE PRESS RELEASES FROM THIS DATE:
Study examines prevalence, characteristics of traumatic brain injuries among adolescents
2013-06-26
"Traumatic brain injury (TBI) among adolescents has been identified as an important health priority. However, studies of TBI among adolescents in large representative samples are lacking. This information is important to the planning and evaluation of injury prevention efforts, particularly because even minor TBI may have important adverse consequences," write Gabriela Ilie, Ph.D., of St. Michael's Hospital, Toronto, Canada, and colleagues, who examined the prevalence of TBI, mechanisms of injury, and adverse correlates in a large representative sample of adolescents living ...
Researchers strike gold with nanotech vaccine
2013-06-26
Scientists in the US have developed a novel vaccination method that uses tiny gold particles to mimic a virus and carry specific proteins to the body's specialist immune cells.
The technique differs from the traditional approach of using dead or inactive viruses as a vaccine and was demonstrated in the lab using a specific protein that sits on the surface of the respiratory syncytial virus (RSV).
The results have been published today, 26 June, in IOP Publishing's journal Nanotechnology by a team of researchers from Vanderbilt University.
RSV is the leading viral cause ...
Death rates from heart disease continue to decline in most of the EU
2013-06-26
Death rates from heart disease in the European Union have more than halved in many countries since the early 1980s, according to new research published online today (Wednesday) in the European Heart Journal [1]. In the majority of countries, there have been ongoing steady reductions in heart disease death rates in both sexes and most age groups, including among younger people, despite increases in obesity and diabetes during this time. However, heart disease remains a leading cause of death in Europe.
The authors of the study say their analysis shows little evidence ...
Study ranks social contacts by job and social group in bid to fight infectious diseases
2013-06-26
In the light of Novel Corona Virus, concerns over H7N9 Influenza in S.E. Asia, and more familiar infections such as measles and seasonal influenza, it is as important as ever to be able to predict and understand how infections transmit through the UK population.
Researchers at the University of Warwick and University of Liverpool have mapped the daily contact networks of thousands of individuals to shed light on which groups may be at highest risk of contracting and spreading respiratory diseases.
These scientists used an anonymous web and postal survey of 5,027 UK residents ...
Overweight causes heart failure -- large study with new method clarifies the association
2013-06-26
An international research team led by Swedish scientists has used a new method to investigate obesity and overweight as a cause of cardiovascular disease. Strong association have been found previously, but it has not been clear whether it was overweight as such that was the cause, or if the overweight was just a marker of another underlying cause, as clinical trials with long-term follow-ups are difficult to implement.
A total of nearly 200,000 subjects were included in the researchers' study of the causality between obesity/overweight and diseases related to cardiovascular ...
Cutlery: Do size, weight, shape and color matter?
2013-06-26
The appearance of cutlery can affect perception of a food's taste, reports BioMed Central's open access journal Flavour. Food tastes saltier when eaten from a knife, and denser and more expensive from a light plastic spoon. Taste was also affected by the color of the cutlery.
The crockery we use has been shown to alter our perception of food and drink. Beverages in cold colored glasses were rated more refreshing and the weight and color of a plate can alter how dense, salty or sweet food tastes. In this study, researchers from the University of Oxford demonstrated that ...
Study shows heart failure survivors at greater risk for cancer
2013-06-26
WASHINGTON (June 25, 2013) — Heart failure patients are surviving more often with the heart condition but they are increasingly more likely to be diagnosed with cancer, a trend that could be attributed to increased surveillance, side effects of treatments, or other causes, according to a study published online today in the Journal of the American College of Cardiology.
"Heart failure patients are not only at an increased risk for developing cancer, but the occurrence of cancer increases mortality in these patients," explained Dr. Veronique Roger, MD, director of the Mayo ...
A deep brain disorder
2013-06-26
A group of investigators from San Diego State University's Brain Development Imaging Laboratory are shedding a new light on the effects of autism on the brain.
The team has identified that connectivity between the thalamus, a deep brain structure crucial for sensory and motor functions, and the cerebral cortex, the brain's outer layer, is impaired in children with autism spectrum disorders (ASD).
Led by Aarti Nair, a student in the SDSU/UCSD Joint Doctoral Program in Clinical Psychology, the study is the first of its kind, combining functional and anatomical magnetic ...
Symptoms of Prader-Willi syndrome associated with interference in circadian, metabolic genes
2013-06-26
(SACRAMENTO, Calif.) — Researchers with the UC Davis MIND Institute and Agilent Laboratories have found that Prader-Willi syndrome — a genetic disorder best known for causing an insatiable appetite that can lead to morbid obesity — is associated with the loss of non-coding RNAs, resulting in the dysregulation of circadian and metabolic genes, accelerated energy expenditure and metabolic differences during sleep.
The research was led by Janine LaSalle, a professor in the UC Davis Department of Medical Microbiology and Immunology who is affiliated with the MIND Institute. ...
Laser guided codes advance single pixel terahertz imaging
2013-06-26
VIDEO:
A new method for single pixel terahertz (THz) imaging developed by Boston College researchers uses a set of instructions delivered by a laser beam to tune THz waves in order...
Click here for more information.
CHESTNUT HILL, MA (June 25, 2013) – The universe is awash in terahertz (THz) waves, as harmless as they are abundant. But unlike other regions of the electromagnetic spectrum, THz has proven to be extremely difficult to manipulate in order to capture novel images ...